Freedom Life Insurance Company Simplifies Insurance Choices

Everyone needs life insurance, but are reluctant to get it because they do not understand the various types of insurance, nor the many companies that claim to be the best. To ensure that insurance company provides understandable explanations of what they offer, and how best they can service your needs, customers need a company that they can trust. Freedom Life Insurance company will take the time to explain all of the necessary factors in choosing a life insurance policy. Life insurance beneficiary amounts and premiums are based on the age of the policy holder. There are basically two types of life insurance, term life, and whole life.

Younger people usually benefit more from term life insurance, because it is based on a specific need. If there are young children in the family, and the policy holder wants to ensure that there will be money for them to attend college, then they get a term life policy. These policies will terminate after a period of time with a cash benefit, if the policy holder out lives the term, that can be used for any reason. Term life insurance can be transformed into a whole life policy after it terminates, without a health examine, but the whole life premiums will be much higher. The experts at Freedom Life Insurance company will gladly give you all of the information needed to make that transition.

Choosing a whole life insurance policy is the option that is available for older people, as well as younger people. This policy lasts for years, and builds up cash value. People can borrow against the policy, and repay it so that the entire policy amount is there when it is needed. Unlike the term life policy, whole life does build equity to be considered as a cash savings. With most whole life policies, the amount of coverage does not decrease, nor will the premiums increase as the person gets older. For any questions regarding life insurance need, the friendly, qualified agents at Freedom Life Insurance company can ensure that you will be able to make a sound decision about your life insurance needs. Check more:

Matthew Autterson Turns His Focus From Finances to Philanthropy

Matthew Autterson is president and CEO of CNS Bioscience, Inc. and serves on the board of Falci Adaptive Biosystems. Before beginning his current endeavors in health solutions and clinical drug development, Matthew Autterson got his start in finances in 1980 after graduating from Michigan State University with a B.A. in Finance. His career started at First Trust Corporation before moving on Integrated Resources, Inc. where he worked with a team to spearhead a new chartered trust company called Resources Trust Company. He went on to achieve the position of president where he helped grow the company to serve more than 200,000 customers and earn over $20 billion in custodial assets over a series of years and multiple acquisitions.

Autterson took his leadership skills for a turn when he started to focus his energy on philanthropy and the health sector. Along with his membership on the Falci Adaptive Biosystems Board of Directors, he has taken leadership roles on many of Colorado’s business foundations including Chairman of the Board of Directors of Denver Hospice. Falci Adaptive Biosystems is a non-profit organization that works to utilize the most recent technology to provide greater mobility to people with neuromotor disabilities. He also currently holds the roles of board member, president and CEO of the drug development company CNS Bioscience, Inc. CNS Bioscience focuses on clinical-stage drugs for neuropathic pain.

Though he pursued a variety of philanthropic endeavors in his community and field including membership in the Young President’s Organization, membership in the World Presidents Organization, serving on the Board of the Denver Zoo, and the Board of Denver Zoological Foundation, Autterson’s focus now is with Falci Adaptive Biosystems and CNS Bioscience. Though these endeavors may seem to be quite different from his background in estate-planning and investment-strategy, his leadership and development skills will prove to be invaluable to these growing organizations. CNS Bioscience, Inc. was founded by Dr. Scott Falci, M.D. in 2013. Dr. Falci is also the chairman and president of Falci Adaptive Biosystems. Autterson’s support of Dr. Falci’s newest company is a natural expansion of his recent work.